Displaying drugs 276 - 300 of 406 in total
| Name | Weight | Structure | Desription | Categories |
|---|---|---|---|---|
| Elapegademase | 115000.0 C1797H2795N477O544S12 |  | A recombinant adenosine deaminase used to treat adenosine deaminase severe combined immune deficiency. | Adenosine Deaminase Inhibitors |
| Eftrenonacog alfa | 98000.0 | | A recombinant Factor IX used to treat and prevent bleeding in hemophilia B. | Amino Acids, Peptides, and Proteins / Biological Factors / Blood Coagulation Factors / Blood Proteins / Enzyme Precursors / Enzymes and Coenzymes / Globulins / Hemostatics / Immunoglobulin Constant Regions / Immunoglobulin Fragments / Immunoglobulins / Immunoproteins / Peptide Fragments / Peptides / Protein Precursors / Proteins / Recombinant Proteins / Serum Globulins |
| Efmoroctocog alfa | 220000.0 C9736H14863N2591O2855S78 | | A recombinant Factor VIII used to treat and prevent bleeding in hemophilia A. | Hemostatics / Human Antihemophilic Factors |
| Eflapegrastim | 72000.0 | | A form of recombinant human granulocyte colony stimulating factor used to induce the production of granulocytes and lower infection risk after myelosuppressive therapy. | Amino Acids, Peptides, and Proteins / Biological Factors / Blood Proteins / Carbohydrates / Colony-Stimulating Factors / Cytokines / Globulins / Glycoconjugates / Glycoproteins / Granulocyte Colony-Stimulating Factors / Hematopoietic Cell Growth Factors / Immunoglobulin Constant Regions / Immunoglobulin Fragments / Immunoglobulins / Immunoproteins / Intercellular Signaling Peptides and Proteins / Leukocyte Growth Factor / Peptide Fragments / Peptides / Proteins / Serum Globulins |
| Efgartigimod alfa | 54000.0 | | A neonatal Fc receptor blocker used to treat generalized myasthenia gravis in patients who are AChR-antibody positive. | Selective Immunosuppressants |
| Efbemalenograstim alfa | Not Available | | A granulocyte-colony stimulating factor used to treat prevent chemotherapy-induced neutropenia. | Colony-Stimulating Factors |
| Efanesoctocog alfa | 312000.0 | | A recombinant DNA-derived, Factor VIII concentrate indicated for routine prophylaxis, on-demand treatment and control of bleeding episodes, and perioperative management of bleeding in patients with hemophilia A. | Amino Acids, Peptides, and Proteins / Biological Factors / Blood Coagulation Factors / Blood Proteins / Factor VIII / Hemostatics / Proteins / Recombinant Fusion Proteins / Recombinant Proteins |
| Efalizumab | Not Available |  | A monoclonal anti-CD11a antibody used to treat moderate to severe plaque psoriasis. | Selective Immunosuppressants |
| Eculizumab | 148000.0 |  | A recombinant humanized monoclonal antibody used to reduce the risk of hemolysis in paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS). | Selective Immunosuppressants |
| Ecallantide | 7054.0 C305H442N88O91S8 | | A kallikrein inhibitor used to prevent and treat acute attacks caused by Hereditary Angioedema (HAE). | Drugs Used in Hereditary Angioedema |
| Durvalumab | 146300.0 C6502H10018N1742O2024S42 | | An antineoplastic monoclonal antibody used to treat urothelial carcinoma and locally advanced, unresectable non-small cell lung cancer. | Antibodies, Monoclonal / PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors |
| Dupilumab | 146896.9522 C6512H10066N1730O2052S46 | | A monoclonal antibody used to treat moderate to severe atopic dermatitis, asthma, and nasal polyps accompanied by chronic rhinosinusitis in adolescents and adults. | Agents for Dermatitis, Excluding Corticosteroids |
| Dulaglutide | 59669.81 C2646H4044N704O836S18 |  | A GLP-1 agonist used to manage type 2 diabetes mellitus. | Glucagon-like peptide-1 (GLP-1) analogues |
| Drotrecogin alfa | 55000.0 C1786H2779N509O519S29 |  | A form of recombinant activated human protein C used to reduce mortality in patients with severe sepsis by inhibiting coagulation Factors V and VIII. | Enzymes |
| Dostarlimab | 144000.0 C6420H9832N1680O2014S44 | | An anti-PD-1 monoclonal antibody used in the treatment of mismatch repair deficient endometrial cancers and solid tumours with no alternative treatment options. | PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors |
| Dornase alfa | 29253.9 C1321H1999N339O396S9 |  | A synthetic form of human deoxyribonuclease I used to break down extracellular DNA in the lungs, a major source of mucous viscosity in cystic fibrosis. | Expectorants |
| Dinutuximab | 145000.0 C6422H9982N1722O2008S48 | | An immunotherapeutic agent used in combination with other immunomodulating agents to treat high-risk neuroblastoma in pediatric patients who achieve at least a partial response to prior first-line multiagent, multimodality therapy. | Antibodies, Monoclonal |
| Digoxin Immune Fab (Ovine) | 47301.7 C2085H3223N553O672S16 |  | An antibody binding fragment which binds digoxin molecules which is used as an antidote to digoxin overdose. | Antidotes / Immunoglobulin G |
| Dibotermin alfa | Not Available | | indicated for the treatment of acute tibia fractures in adults, as an adjunct to standard care using open fracture reduction and intramedullary unreamed nail fixation [FDA Label]. indicated for single-level... | Bone Morphogenetic Proteins |
| Desirudin | C287H440N80O110S6 | | Indicated as prophylaxis of deep vein thrombosis for patients undergoing hip replacement surgery. | Anticoagulants / Antithrombins |
| Denosumab | 144700.0 C6404H9912N1724O2004S50 |  | A RANK ligand (RANKL) inhibitor used for the management of osteoporosis in patients at high risk for bone fractures. | Antibodies, Monoclonal, Humanized / Bone Density Conservation Agents / RANK Ligand Inhibitor |
| Denileukin diftitox | 57647.3 C2560H4042N678O799S17 |  | A recombinant cytotoxic protein based on a combination of diphtheria toxin fragments and interleukin-2 used to treat cutaneous T-cell lymphoma by targeting the interleukin-2 receptor. | Antineoplastic Agents |
| DaxibotulinumtoxinA | 150000.0 | | A botulinum toxin used to treat glabellar lines and cervical dystonia in adults. | Acetylcholine Release Inhibitors / Botulinum Toxins / Botulinum Toxins, Type A / Central Nervous System Depressants / Muscle Relaxants / Muscle Relaxants, Peripherally Acting Agents / Musculo-Skeletal System / Neuromuscular Agents / Neuromuscular Blocking Agents |
| Dasiglucagon | 3382.0 C152H222N38O50 | | A glucagon analog used to treat severe hypoglycemia in pediatric and adult patients with diabetes. | Glycogenolytic Hormones |
| Darbepoetin alfa | 18396.1 C815H1317N233O241S5 |  | A recombinant form of human erythropoietin used to increase differentiation of progenitor cells to red blood cells in the treatment of anemia. | Erythropoiesis-Stimulating Agents / Hematinics |
Displaying drugs 276 - 300 of 406 in total